NCT02785406View on ClinicalTrials.gov

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Cocaine Use DisorderAnxiety
Interventions
DRUG

suvorexant

Subjects will receive suvorexant capsules (10 mg week 1, 20 mg week 2), once daily at 10 PM.

DRUG

Placebo (for suvorexant)

Subjects will receive placebo capsules once daily at 10 PM.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

Peter McManus Charitable Trust

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER

NCT02785406 - Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use | Biotech Hunter | Biotech Hunter